|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 27 April 2005
doi: 10.1242/dev.01842
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

1 Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto M5G 1X5,
Canada
2 Max-Planck Institute of Immunobiology, Department of Molecular Embryology,
Freiburg 79108, Germany
3 Kyoto University Graduate School of Medicine, Department of Pharmacology,
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan
4 University of Toronto, Department of Medical Genetics and Microbiology,
Toronto M5S 1A8, Canada
Author for correspondence (e-mail:
rossant{at}mshri.on.ca)
Accepted 30 March 2005
Differential gene regulation integrated in time and space drives developmental programs during embryogenesis. To understand how the program of gastrulation is regulated by Wnt/ß-catenin signaling, we have used genome-wide expression profiling of conditional ß-catenin mutant embryos. Known Wnt/ß-catenin target genes, known components of other signaling pathways, as well as a number of uncharacterized genes were downregulated in these mutants. To further narrow down the set of differentially expressed genes, we used whole-mount in situ screening to associate gene expression with putative domains of Wnt activity. Several potential novel target genes were identified by this means and two, Grsf1 and Fragilis2, were functionally analyzed by RNA interference (RNAi) in completely embryonic stem (ES) cell-derived embryos. We show that the gene encoding the RNA-binding factor Grsf1 is important for axial elongation, mid/hindbrain development and axial mesoderm specification, and that Fragilis2, encoding a transmembrane protein, regulates epithelialization of the somites and paraxial mesoderm formation. Intriguingly, the knock-down phenotypes recapitulate several aspects of Wnt pathway mutants, suggesting that these genes are components of the downstream Wnt response. This functional genomic approach allows the rapid identification of functionally important components of embryonic development from large datasets of putative targets.
Key words: Wnt/ß-catenin signaling, Gastrulation, RNA interference (RNAi), Target genes, Expression profiling, Grsf1, Fragilis2, Functional genomics
This article has been cited by other articles:
![]() |
H. Hatano, Y. Kudo, I. Ogawa, T. Tsunematsu, A. Kikuchi, Y. Abiko, and T. Takata IFN-Induced Transmembrane Protein 1 Promotes Invasion at Early Stage of Head and Neck Cancer Progression Clin. Cancer Res., October 1, 2008; 14(19): 6097 - 6105. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. C. Lange, D. J. Adams, C. Lee, S. Barton, R. Schneider, A. Bradley, and M. A. Surani Normal Germ Line Establishment in Mice Carrying a Deletion of the Ifitm/Fragilis Gene Family Cluster Mol. Cell. Biol., August 1, 2008; 28(15): 4688 - 4696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ufer, C. C. Wang, M. Fahling, H. Schiebel, B. J. Thiele, E. E. Billett, H. Kuhn, and A. Borchert Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development Genes & Dev., July 1, 2008; 22(13): 1838 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Dunty Jr, K. K. Biris, R. B. Chalamalasetty, M. M. Taketo, M. Lewandoski, and T. P. Yamaguchi Wnt3a/ -catenin signaling controls posterior body development by coordinating mesoderm formation and segmentation Development, January 1, 2008; 135(1): 85 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Dequeant, E. Glynn, K. Gaudenz, M. Wahl, J. Chen, A. Mushegian, and O. Pourquie A Complex Oscillating Network of Signaling Genes Underlies the Mouse Segmentation Clock Science, December 8, 2006; 314(5805): 1595 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Andreu, S. Colnot, C. Godard, P. Laurent-Puig, D. Lamarque, A. Kahn, C. Perret, and B. Romagnolo Identification of the IFITM Family as a New Molecular Marker in Human Colorectal Tumors Cancer Res., February 15, 2006; 66(4): 1949 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bartz and A. L. Jackson How Will RNAi Facilitate Drug Development? Sci. Signal., August 2, 2005; 2005(295): pe39 - pe39. [Abstract] [Full Text] [PDF] |
||||